During the past decade, Oncology/Hematology Care Clinical Trials LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology/Hematology Care Clinical Trials LLC" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology/Hematology Care Clinical Trials LLC" #1 collaborator was "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Oncology/Hematology Care Clinical Trials LLC" are "Non-Small Cell Lung Cancer" (2 trials), "Solid Tumors" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Oncology/Hematology Care Clinical Trials LLC" in a lesser frequency.

Most popular intervention types in "Oncology/Hematology Care Clinical Trials LLC" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "5 fluorouracil" (1 trials), "5-Fluorouracil" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology/Hematology Care Clinical Trials LLC" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology/Hematology Care Clinical Trials LLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Oncology/Hematology Care Clinical Trials LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology/Hematology Care Clinical Trials LLC, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".